🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
The goal of the proposed project is to see if an innovative family-based in...
Status
Completed
Location
University of Minnesota, School of Nursing
Start Date
2016-03
Trial ID
NCT02973815
Treatments Being Tested
Investigators will conduct a pilot randomized controlled trial assessing th...
Status
Recruiting
Location
Seattle Children's Research Institute
Start Date
2022-07-10
Trial ID
NCT05722535
Treatments Being Tested
The aim of this study is to compare the efficacy of various treatment optio...
Status
Withdrawn
Location
University of California-Davis, Department of Dermatology
Start Date
2014-06
Trial ID
NCT02090517
This prospective, randomized study aims to comprehensively evaluate the imp...
Status
Recruiting
Location
Thomas Jefferson University Hospitals
Start Date
2024-09-01
Trial ID
NCT06632587
Treatments Being Tested
SIR-POSA is a phase II trial of peripheral blood stem cell (PBSC) transplan...
Status
Completed
Location
Ospedale San Raffaele
Start Date
2018-06-18
Trial ID
NCT03434704
This phase I trial studies the side effects and best dose of genetically mo...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2013-10-08
Trial ID
NCT01815749
Intervention randomized controlled open study with 2 parallel arms . The ob...
Status
Completed
Location
Multiple Locations
Start Date
2012-02
Trial ID
NCT02715440
Treatments Being Tested
The treatments that aim to cure cancer in children can lead to "late effect...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-10
Trial ID
NCT05832138
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of linsitinib ...
Status
Withdrawn
Location
OHSU Knight Cancer Institute
Start Date
2011-12
Trial ID
NCT01465815